We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Vibrational Microspectroscopy Detects Presence of Metastatic Cancer Cells

By Labmedica staff writers
Posted on 19 May 2008
An automatic method based on vibrational microspectroscopy identifies the presence of metastatic cancer cells without the need for staining, and without human input.

The method aids classical cytology (where visual inspection is used to detect changes in the morphology of cells obtained from bodily fluids, exfoliation, or thin needle biopsy) and classical pathology (where stained tissue sections are examined visually). More...
As disease changes the chemical composition of the cell, the newly developed instrument is able to detect variations in cellular properties without the need to stain the slides and inspect them visually.

The machine-based and computer-interpreted technology, which enhances the accuracy and alleviates the physical strain on the human observer, was developed by scientists from the department of chemistry and chemical biology and the Center for Subsurface Sensing and Imaging Systems (CenSISS) at Northeastern University (Boston, MA, USA). "The idea behind the methodology is to examine the chemical composition of cells, as opposed to relying solely on the morphology,” said Prof. Max Diem from the chemistry and chemical biology department. "Abnormalities in exfoliated cells, for instance in Pap smears, can be difficult to discern visually, however, by looking at the biochemical composition of the cell with the help of vibrational spectroscopy, we can detect specific cellular changes indicating cancer.”

The investigators are working on developing an operating room-based instrument that will produce a diagnosis of breast cancer cells in the axillary lymph nodes within 15 minutes after excision. The goal is to produce instrumentation and software that can analyze lymph node sections in the operating room, and provide the surgeon with an objective diagnosis of the spread of disease.


Related Links:
Northeastern University

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Adjustable Mobile Barrier
M-458
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.